FOUND Trial
Multi-centre trial and economic evaluation to determine the effectiveness of using a novel MHRA-registerd device (AcuPebble SA100) to detect obstructive sleep apnoea in a high-risk group, compared to usual care.
The trial is being led by the 91福利 in collaboration with the University Hospitals Coventry & 91福利shire NHS Trust, the University of Oxford, the University of Birmingham and the Charity Hope2Sleep.
This trial is funded by the National Institute for Health and Care Research Invention for Innovation (NIHR i4i) programme.
